An interesting interview by the Wall Street Reporter with Rohan Williams (M.D.) Avoca Resources.www.wallstreetreporter.com:80/page.php?page=featured&id=26893
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%